Investors finally get a glimpse of Zai Lab Limited ADR (ZLAB) volume hitting the figure of 1.4 million.

Zai Lab Limited ADR (NASDAQ: ZLAB) kicked off on Friday, down -5.33% from the previous trading day, before settling in for the closing price of $33.80. Over the past 52 weeks, ZLAB has traded in a range of $15.05-$39.77.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 118.89%. While this was happening, its average annual earnings per share was recorded 43.20%. With a float of $108.80 million, this company’s outstanding shares have now reached $109.84 million.

The extent of productivity of a business whose workforce counts for 1869 workers is very important to gauge. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.

Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 52.78%. The most recent insider transaction that took place on Apr 04 ’25, was worth 111,044. In this transaction an insider of this company sold 3,354 shares at a rate of $33.11, taking the stock ownership to the 67,345 shares. Before that another transaction happened on Apr 04 ’25, when Company’s Chief Legal Officer sold 1,874 for $33.11, making the entire transaction worth $62,044. This insider now owns 30,375 shares in total.

Zai Lab Limited ADR (ZLAB) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 43.20% per share during the next fiscal year.

Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators

Take a look at Zai Lab Limited ADR’s (ZLAB) current performance indicators. Last quarter, stock had a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.81.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach 0.25 in one year’s time.

Technical Analysis of Zai Lab Limited ADR (ZLAB)

The latest stats from [Zai Lab Limited ADR, ZLAB] show that its last 5-days average volume of 1.12 million was superior to 1.1 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.21%. Additionally, its Average True Range was 2.46.

During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 51.29%, which indicates a significant decrease from 74.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 122.84% in the past 14 days, which was higher than the 69.08% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $33.41, while its 200-day Moving Average is $26.45. Now, the first resistance to watch is $33.05. This is followed by the second major resistance level at $34.09. The third major resistance level sits at $34.77. If the price goes on to break the first support level at $31.33, it is likely to go to the next support level at $30.65. The third support level lies at $29.61 if the price breaches the second support level.

Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats

The company with the Market Capitalisation of 3.51 billion has total of 110,128K Shares Outstanding. Its annual sales at the moment are 398,990 K in contrast with the sum of -257,100 K annual income. Company’s last quarter sales were recorded 109,070 K and last quarter income was -81,680 K.